How to appeal a CareFirst BCBS interventional radiology — ufe, pae, tips, y-90, tumor ablation, kyphoplasty denial

The framework that applies to your appeal

Federal law gives you the right to a full and fair internal appeal, then an external review by an independent third party.

CareFirst BCBS-specific note: BCBS licensee for Maryland, DC, and northern Virginia (~3.5M members). Operates as non-profit. Appeals jurisdiction depends on policy issue location — MIA (MD), DISB (DC), or SCC Bureau of Insurance (VA). CVS Caremark is the PBM.

What CareFirst BCBS's policy requires for interventional radiology — ufe, pae, tips, y-90, tumor ablation, kyphoplasty

Cited policy: Anthem clinical guideline Vertebroplasty and Kyphoplasty (BCBS plans similar)

Acute (<6-12 wk) painful VCF on MRI STIR/T2 edema confirmation; refractory to >=4-6 wk conservative therapy (analgesics, brace, PT); pain NRS >=5; underlying osteoporosis or pathologic fracture; absence of retropulsion / cord compression / unstable fracture; absence of contraindication.

How CareFirst BCBS denies interventional radiology — ufe, pae, tips, y-90, tumor ablation, kyphoplasty — and how to counter it

Where CareFirst BCBS pushes back: 1) Fracture not documented as acute (no STIR/T2); 2) Conservative therapy duration insufficient; 3) Citing INVEST / Buchbinder / Kallmes negative trials as evidence of futility; 4) Multilevel cement augmentation 'excessive'.

Counter-arguments that hold up: Cite VAPOUR (Clark Lancet 2016) — vertebroplasty positive for severe acute VCF; VERTOS IV (Firanescu BMJ 2018) — positive vs sham; AANS/CNS/SIR/ASNR/ASSR Practice Parameter on Vertebral Augmentation; NASS Coverage Policy. Submit MRI with STIR/T2 edema confirming acuity. Distinguish VAPOUR / VERTOS IV inclusion criteria (acute, severe pain, edema-positive) from older negative trials (chronic / asymptomatic / mixed).

What CareFirst BCBS typically denies for interventional radiology — ufe, pae, tips, y-90, tumor ablation, kyphoplasty

Across CareFirst BCBS's commercial and Medicare books, denials cluster around a small number of patterns. For interventional radiology — ufe, pae, tips, y-90, tumor ablation, kyphoplasty, expect:

• DC/MD/VA cross-jurisdiction issues
• Step therapy on specialty drugs via CVS Caremark
• Behavioral health network adequacy
• BlueChoice HMO referral denials

Treatments most often denied in this category

These are the interventional radiology — ufe, pae, tips, y-90, tumor ablation, kyphoplasty treatments most often flagged for prior auth, step therapy, or medical necessity review:

• UFE (uterine fibroid embolization)
• PAE (prostate artery embolization)
• TIPS
• Y-90 radioembolization
• TACE (HCC)
• Cryoablation

How to submit the appeal to CareFirst BCBS

1. Read the denial letter — note the exact denial reason code and the appeal deadline (180 days from the date on the letter).
2. Gather supporting documentation: physician letter of medical necessity, relevant clinical notes, peer-reviewed citations supporting the treatment for your indication, and the policy or coverage document CareFirst BCBS cited in the denial.
3. File the appeal through CareFirst BCBS's portal (members: https://member.carefirst.com ; providers: https://provider.carefirst.com). Standard decision returns within 30 days; expedited urgent appeals return within 72 hours.
4. If denied again, request external review by an independent reviewer within 4 months of the final internal denial. In MD, the state insurance department coordinates external review for fully-insured plans; ERISA self-funded plans use a federal external review through DOL/EBSA.

Clinician or prior-auth team handling this on the practice side? See CareFirst BCBS's prior-authorization criteria by drug: CareFirst BCBS PA criteria on ApprovalHelp.